In the Boardroom

Filter

Current filters:

None

Popular Filters

1 to 25 of 161 results

Allergan names Jim Hindman chief financial officer

Allergan names Jim Hindman chief financial officer

19-08-2014

Allergy specialist Allergan has appointed Jim Hindman as chief financial officer, effective immediately,…

AllerganBoardroomBusiness FinanceBusiness FinanceChief financial officerJim HindmanPharmaceuticalUSA

Basilea appoints David Veitch as chief commercial officer

Basilea appoints David Veitch as chief commercial officer

19-08-2014

Switzerland-based Basilea Pharmaceutica has appointed David Veitch as its chief commercial officer.

Basilea PharmaceuticaBoardroomPharmaceuticalSwitzerland

Oxford BioMedica appoints former Aeterna Zentaris senior vice president Paul Blake as chief development officer

Oxford BioMedica appoints former Aeterna Zentaris senior vice president Paul Blake as chief development officer

15-08-2014

British gene and cell therapy company Oxford BioMedica has appointed Paul Blake as chief development…

BiotechnologyBoardroomOxford BioMedicaPaul BlakeUK

Synta appoints Sanofi's Anne Whitaker as chief executive

Synta appoints Sanofi's Anne Whitaker as chief executive

12-08-2014

Coming from her position as president of Sanofi’s North American pharma division, Anne Whitaker has…

Anne WhitakerBoardroomBreast cancerElesclomolOncologyPharmaceuticalSafi R. BahcallSanofiSynta PharmaceuticalsUSA

Milestone appoints Francis Plat as chief medical officer

Milestone appoints Francis Plat as chief medical officer

21-07-2014

Quebec-based cardiovascular drug development specialist Milestone Pharmaceuticals has announced the appointment…

BoardroomCanadaCardio-vascularFrancis PlatMilestone PharmaceuticalsPharmaceutical

Aptuit names Paul Overton executive vice president of business development and marketing

Aptuit names Paul Overton executive vice president of business development and marketing

16-07-2014

US-based drug development and discovery company Aptuit has appointed Paul Overton as executive vice president,…

AptuitBoardroomPharmaceuticalUSA

Jounce appoints Richard Murray from Merck

Jounce appoints Richard Murray from Merck

11-07-2014

US-based oncology specialist Jounce Therapeutics has announced the appointment of Richard Murray to chief…

BoardroomJounce TherapeuticsMerck & Co.OncologyPharmaceuticalRichard Murray

Oxford BioTherapeutics appoints Eugen Leo as head of clinical development

Oxford BioTherapeutics appoints Eugen Leo as head of clinical development

11-07-2014

UK-based biotech company Oxford BioTherapeutics, focusing on antibody-drug conjugates in the treatment…

BiotechnologyBoardroomOxford BioTherapeuticsUK

Nuevolution names Paul Workman as scientific advisor

Nuevolution names Paul Workman as scientific advisor

09-07-2014

Biochemist and cancer pharmacologist Paul Workman has joined Copenhagen-based pharmaceutical company…

BoardroomDenmarkNuevolutionPaul Workman

ALK appoints new Executive Vice President for Product Supply

ALK appoints new Executive Vice President for Product Supply

01-07-2014

Danish allergy specialist ALK-Abello has appointed Helle Skov as new Executive Vice President (Product…

ALK AbelloAlk-AbelloBoardroomDenmarkPharmaceutical

Pharma translation company Conversis Medical appoints Mark Hooper

Pharma translation company Conversis Medical appoints Mark Hooper

26-06-2014

Specialist medical translation agency Conversis Medical has announced the appointment of Mark Hooper…

BoardroomPharmaceutical sciencesPharmacology

Retrogenix names Matthew Britz as North American Business Development Director

23-06-2014

Biotechnology firm Retrogenix has announces the appointment of Matthew Britz as North American Business…

BiotechnologyBoardroomUSA

Teva chairman to step down by year end

Teva chairman to step down by year end

18-06-2014

The chairman of Israel-based Teva Pharmaceutical Industries, the world’s largest generic drugs company,…

BoardroomGenericsManagementTeva Pharmaceutical Industries

UK’s Summit sets up operations in the USA

UK’s Summit sets up operations in the USA

17-06-2014

UK drug discovery firm Summit, which is focused on therapies for Duchenne muscular dystrophy and Clostridium…

Antibiotics and Infectious diseasesBoardroomManagementPharmaceuticalRare diseasesResearchSummit PharmaceuticalsUSA

6,000 new jobs in Novo Nordisk create a further 15,000 jobs in Denmark

6,000 new jobs in Novo Nordisk create a further 15,000 jobs in Denmark

11-06-2014

Up to 2022, Danish diabetes care giant Novo Nordisk expects to hire 6,000 new employees in Denmark, half…

BoardroomDenmarkDiabetesManagementNovo NordiskPharmaceutical

Dendreon chief to step down for personal reasons

Dendreon chief to step down for personal reasons

10-06-2014

US biotech firm Dendreon revealed last evening that John Johnson plans to step down as president and…

BiotechnologyBoardroomDendreonManagementProvenge

1 to 25 of 161 results

Back to top